Improving Outcomes in Mental Health (IOMH)-an Australian longitudinal clinical study of families with children with neurodevelopmental problems: cohort profile.
Galligan DE. et al, (2025), BMJ open, 15
Mental health and sleep correlates of self-reported outdoor daylight exposure in over 13,000 adults with depression.
Crouse JJ. et al, (2025), European psychiatry : the journal of the Association of European Psychiatrists, 1 - 34
Connecting genomic results for psychiatric disorders to human brain cell types and regions reveals convergence with functional connectivity.
Yao S. et al, (2025), Nature communications, 16
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies.
Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk None. and Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium None., (2025), Cell
Genome-wide meta-analyses of non-response to antidepressants identify novel loci and potential drugs.
Koch E. et al, (2024), Res Sq
Genome-wide copy number variation association study in anorexia nervosa.
Walker A. et al, (2024), Molecular psychiatry
Sex-Specific Association Between Genetic Risk of Psychiatric Disorders and Cardiovascular Diseases.
Jiang J-C. et al, (2024), Circulation. Genomic and precision medicine
Changes in sleep patterns in people with a history of depression during the COVID-19 pandemic: a natural experiment.
Shin M. et al, (2024), BMJ mental health, 27
F58. COHORT PROFILE: IMPROVING OUTCOMES OF MENTAL HEALTH (IOMH) A LONGITUDINAL CLINICAL STUDY OF FAMILIES WITH CHILDREN WITH NEURODEVELOPMENTAL PROBLEMS
Galligan D. et al, (2024), European Neuropsychopharmacology, 87, 236 - 237
GENOME-WIDE FINE-MAPPING IMPROVES IDENTIFICATION OF CAUSAL VARIANTS
Zeng J. et al, (2024), European Neuropsychopharmacology, 87, 12 - 13
LATEST INSIGHTS FROM MULTI-ANCESTRY FINE-MAPPING IN PSYCHIATRIC DISORDERS
Koromina M. and Wray N., (2024), European Neuropsychopharmacology, 87, 11 - 11
MENDELIAN RANDOMIZATION – WHAT ARE THE PROMISES?
Schwab S. and Wray N., (2024), European Neuropsychopharmacology, 87, 9 - 10
T47. A MULTI-OMIC QTL ANALYSIS OF MAJOR DEPRESSIVE DISORDER
Nisbet L. et al, (2024), European Neuropsychopharmacology, 87, 181 - 181
Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts
Adams MJ. et al, (2024), Psychological Medicine, 1 - 10
Sex Matters in Cardiovascular Research: A Higher Genetic Risk of Depression is a Greater Risk Factor for Cardiovascular Diseases in Females
Jiang J. et al, (2024), Heart, Lung and Circulation, 33, S316 - S316